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In recent years whole-exome sequencing has been devel-
oped, a technique by which all exons of the genome (all the
protein-coding DNA) can be sequenced at once. Here we
show that whole-exome sequencing, using either 35 or
50 Mb Agilent kits for exome capture, was insufficient to
detect pathogenic DYNC2H1 variants in patients with
Jeune asphyxiating thoracic dystrophy (ATD; MIM208500).
Jeune syndrome is a rare inherited ciliopathy involving
chondrodysplasia characterized by shortened ribs and long
bones, and polydactyly, progressive kidney and liver disease
as well as retinitis pigmentosa. Reduced thoracic capacity
causes approximately 60% early lethality. DYNC2H1
encodes a subunit of the dynein 1B motor that drives tip-
to-base ciliary intraflagellar transport, and mutations have
previously been associated both with embryonically lethal
short rib-polydactyly and the milder, but overlapping Jeune
aspyxiating thoracic dystrophy. Although the DYNC2H1
gene was targeted in our whole-exome experiments many
sequence reads were not properly aligned, resulting in 30-
70% of the gene not being covered. Only a combination of
whole-exome sequencing and a candidate gene approach
(i.e. analysis of non-covered DYNC2H1 exons using Sanger
sequencing) enabled us to detect the missing DYNC2H1
mutations. Whole-exome data analysis of the 90 exon
DYNC2H1 gene is therefore comparable to playing ‘hide
and seek’, whereby certain mutations are easier to find than
others according to their relative coverage. In conclusion,
although whole-exome sequencing has revolutionized the
field of human genetics, our findings emphasize that next-
generation sequencing also presents significant challenges
for gene identification and for implementation of this tech-
nique in DNA diagnostics.
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